Literature DB >> 11724158

Update: Investigation of bioterrorism-related anthrax, 2001.

.   

Abstract

This report updates the investigation of bioterrorism-related anthrax and the provision of antimicrobial prophylaxis to exposed persons and highlights CDC assistance to other countries investigating cases of bioterrorism-related anthrax. Since November 7, 2001, CDC and state and local public health agencies have identified no new cases of bioterrorism-related anthrax. As of November 14, a total of 22 cases of anthrax has met the CDC case definition; 10 were confirmed inhalational anthrax, and 12 (seven confirmed and five suspected) were cutaneous anthrax. Investigation of a case of inhalational anthrax in a hospital stock room worker aged 61 years in New York City (NYC) found no evidence of anthrax contamination at the work site or home; the source of exposure is unknown. Environmental clean-up of contaminated facilities continues, and surveillance for newcases of bioterrorism-related anthrax is ongoing in Delaware (DE), District of Columbia (DC), Florida (FL), Maryland (MD), New Jersey (NJ), NYC, Pennsylvania (PA), Virginia (VA), and other states.

Entities:  

Mesh：

Substances：

Year:  2001        PMID： 11724158

Source DB:  PubMed          Journal:  MMWR Morb Mortal Wkly Rep        ISSN： 0149-2195            Impact factor:   17.586


  24 in total

1.  Response to bioterrorism. Terror weapons are regarded as weapons of mass destruction.

Authors:  Meng-Kin Lim
Journal:  BMJ       Date:  2002-02-09

2.  Modeling the optimum duration of antibiotic prophylaxis in an anthrax outbreak.

Authors:  Ron Brookmeyer; Elizabeth Johnson; Robert Bollinger
Journal:  Proc Natl Acad Sci U S A       Date:  2003-07-30       Impact factor: 11.205

3.  Reaerosolization of fluidized spores in ventilation systems.

Authors:  Paula Krauter; Arthur Biermann
Journal:  Appl Environ Microbiol       Date:  2007-02-09       Impact factor: 4.792

4.  Comprehensive Laboratory Evaluation of a Highly Specific Lateral Flow Assay for the Presumptive Identification of Bacillus anthracis Spores in Suspicious White Powders and Environmental Samples.

Authors:  Jason G Ramage; Kristin W Prentice; Lindsay DePalma; Kodumudi S Venkateswaran; Sruti Chivukula; Carol Chapman; Melissa Bell; Shomik Datta; Ajay Singh; Alex Hoffmaster; Jawad Sarwar; Nishanth Parameswaran; Mrinmayi Joshi; Nagarajan Thirunavkkarasu; Viswanathan Krishnan; Stephen Morse; Julie R Avila; Shashi Sharma; Peter L Estacio; Larry Stanker; David R Hodge; Segaran P Pillai
Journal:  Health Secur       Date:  2016 Sep-Oct

5.  Operational evaluation of high-throughput community-based mass prophylaxis using Just-in-time training.

Authors:  James D Spitzer; Nathaniel Hupert; Jonathan Duckart; Wei Xiong
Journal:  Public Health Rep       Date:  2007 Sep-Oct       Impact factor: 2.792

6.  PCR assay to detect Bacillus anthracis spores in heat-treated specimens.

Authors:  A Fasanella; S Losito; R Adone; F Ciuchini; T Trotta; S A Altamura; D Chiocco; G Ippolito
Journal:  J Clin Microbiol       Date:  2003-02       Impact factor: 5.948

7.  Bioterrorism-related anthrax: international response by the Centers for Disease Control and Prevention.

Authors:  Christina S Polyak; Jonathan T Macy; Margarita Irizarry-De La Cruz; James E Lai; Jay F McAuliffe; Tanja Popovic; Segaran P Pillai; Eric D Mintz
Journal:  Emerg Infect Dis       Date:  2002-10       Impact factor: 6.883

8.  Antimicrobial postexposure prophylaxis for anthrax: adverse events and adherence.

Authors:  Colin W Shepard; Montse Soriano-Gabarro; Elizabeth R Zell; James Hayslett; Susan Lukacs; Susan Goldstein; Stephanie Factor; Joshua Jones; Renee Ridzon; Ian Williams; Nancy Rosenstein
Journal:  Emerg Infect Dis       Date:  2002-10       Impact factor: 6.883

9.  Call-tracking data and the public health response to bioterrorism-related anthrax.

Authors:  Joshua A Mott; Tracee A Treadwell; Thomas W Hennessy; Paula A Rosenberg; Mitchell I Wolfe; Clive M Brown; Jay C Butler
Journal:  Emerg Infect Dis       Date:  2002-10       Impact factor: 6.883

10.  Investigation of bioterrorism-related anthrax, United States, 2001: epidemiologic findings.

Authors:  Daniel B Jernigan; Pratima L Raghunathan; Beth P Bell; Ross Brechner; Eddy A Bresnitz; Jay C Butler; Marty Cetron; Mitch Cohen; Timothy Doyle; Marc Fischer; Carolyn Greene; Kevin S Griffith; Jeannette Guarner; James L Hadler; James A Hayslett; Richard Meyer; Lyle R Petersen; Michael Phillips; Robert Pinner; Tanja Popovic; Conrad P Quinn; Jennita Reefhuis; Dori Reissman; Nancy Rosenstein; Anne Schuchat; Wun-Ju Shieh; Larry Siegal; David L Swerdlow; Fred C Tenover; Marc Traeger; John W Ward; Isaac Weisfuse; Steven Wiersma; Kevin Yeskey; Sherif Zaki; David A Ashford; Bradley A Perkins; Steve Ostroff; James Hughes; David Fleming; Jeffrey P Koplan; Julie L Gerberding
Journal:  Emerg Infect Dis       Date:  2002-10       Impact factor: 6.883
View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.